首页> 外文期刊>Acta Crystallographica Section F >Cloning, expression, purification, crystallization and preliminary X-ray crystallographic study of the putative SAICAR synthetase (PH0239) from Pyrococcus horikoshii OT3
【24h】

Cloning, expression, purification, crystallization and preliminary X-ray crystallographic study of the putative SAICAR synthetase (PH0239) from Pyrococcus horikoshii OT3

机译:horikoshii OT3拟南芥SAICAR合成酶(PH0239)的克隆,表达,纯化,结晶和初步X射线晶体学研究

获取原文
获取原文并翻译 | 示例
           

摘要

The study of proteins involved in de novo biosynthesis of purine nucleotides is central in the development of antibiotics and anticancer drugs. In view of this, a protein from the hyperthermophile Pyrococcus horikoshii OT3 was isolated, purified and crystallized using the microbatch method. Its primary structure was found to be similar to that of SAICAR synthetase, which catalyses the seventh step of de novo purine biosynthesis. A diffraction-quality crystal was obtained using Hampton Research Crystal Screen II condition No. 34, consisting of 0.05 M cadmium sulfate hydrate, 0.1 M HEPES buffer pH 7.5 and 1.0 M sodium acetate trihydrate, with 40%(v/v) 1,4-butanediol as an additive. The crystal belonged to space group P31, with unit-cell parameters a = b = 95.62, c = 149.13 Å. Assuming the presence of a hexamer in the asymmetric unit resulted in a Matthews coefficient (VM) of 2.3 Å3 Da−1, corresponding to a solvent content of about 46%. A detailed study of this protein will yield insights into structural stability at high temperatures and should be highly relevant to the development of antibiotics and anticancer drugs targeting the biosynthesis of purine nucleotides.
机译:涉及嘌呤核苷酸从头生物合成的蛋白质的研究是开发抗生素和抗癌药物的核心。鉴于此,使用微分批法从嗜热嗜热球菌OT3中分离,纯化和结晶蛋白质。发现其主要结构与SAICAR合成酶的结构相似,后者催化从头进行嘌呤生物合成的第七步。使用Hampton Research Crystal Screen II条件No.34(由0.05 M的硫酸镉水合物,0.1 M的HEPES缓冲液pH 7.5和1.0 M的三水合乙酸钠组成)以40%(v / v)1,4构成衍射质量的晶体。 -丁二醇作为添加剂。该晶体属于空间群P3 1 ,单位晶胞参数a = b = 95.62,c = 149.13Å。假设不对称单元中存在六聚体,则马修斯系数(V M )为2.3Åsup3 Da -1 溶剂含量约为46%。对该蛋白质的详细研究将深入了解高温下的结构稳定性,并且应与针对嘌呤核苷酸生物合成的抗生素和抗癌药物的开发高度相关。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号